Report cover image

Elekta AB (EKTA B) - Product Pipeline Analysis, 2022 Update

Publisher GlobalData
Published Sep 08, 2022
Length 40 Pages
SKU # GBDT17412440

Description

Summary Elekta AB (Elekta) is a medical technology company that offers image guided clinical solutions, comprehensive information systems and services for the management of brain disorders and improved cancer care. Its major products include Gamma knife and Extend system; stereotactic system; fully integrated stereotactic radiation therapy system; system for volumetric arc modulated therapy; image guided radiation therapy systems; advanced digital treatment systems; treatment planning systems; electronic brachy therapy for skin cancer; and automated remote after loading platform. It also offers oncology information systems for radiation oncology and medical oncology, treatment planning software, cancer registry and soft tissue visualization software, among others. The company operates in North America, Europe, the Middle East, Africa and Asia-Pacific. Elekta is headquartered in Stockholm, Sweden. This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. Scope: - The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments - The report analyzes all pipeline products in development for the company Elekta AB - The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status) - The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date - The report provides detailed description of products in development, technical specification and functions - The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date. Reasons to Buy: - Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape - Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio - To formulate effective Research & Development strategies - Develop market-entry and market expansion strategies - Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return - Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc - Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio Note: Some sections may be missing if data is unavailable for the company

Table of Contents

40 Pages
Elekta AB Company Overview
Elekta AB Company Snapshot
Elekta AB Pipeline Products and Ongoing Clinical Trials Overview
Elekta AB – Pipeline Analysis Overview
Business Description
Elekta AB - Key Facts
Elekta AB - Major Products and Services
Elekta AB Pipeline Products by Development Stage
Elekta AB Ongoing Clinical Trials by Trial Status
Elekta AB Pipeline Products Overview
Digital Patient Monitoring Algorithm - Melanoma
Digital Patient Monitoring Algorithm - Melanoma Product Overview
Elekta Esprit
Elekta Esprit Product Overview
Elekta Unity
Elekta Unity Product Overview
Elekta Unity Clinical Trial
Harmony Pro
Harmony Pro Product Overview
MOSAIQ Mobile
MOSAIQ Mobile Product Overview
Next generation Gamma Knife
Next generation Gamma Knife Product Overview
Next generation Gamma Knife Clinical Trial
Elekta AB - Key Competitors
Elekta AB - Key Employees
Elekta AB - Key Employee Biographies
Elekta AB - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Elekta AB, Recent Developments
May 09, 2022: Elekta and Netherlands Cancer Institute partner on radiation therapies
Apr 05, 2022: GE Healthcare, Elekta collaborate to expand access to precision radiation therapy solutions
Feb 14, 2022: Elekta announces preliminary third quarter results
Feb 04, 2022: Invitation to the presentation of Elekta's third quarter 2021/22
Nov 04, 2021: Invitation to the presentation of Elekta's second quarter 2021/22
Aug 23, 2021: Kaiku Health to present research with Docrates Cancer Center and Hirslanden Institut für Radiotherapie at ESTRO 2021
Aug 11, 2021: Invitation to the presentation of Elekta's first quarter 2021/22
Jul 21, 2021: Notice to the Annual General Meeting of Elekta
Jul 09, 2021: Elekta's Annual Report for 2020/21 available
Jun 07, 2021: Elekta's new strategy to focus on growth and access to radiation therapy
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Table 1: Elekta AB Pipeline Products and Ongoing Clinical Trials Overview
Table 2: Elekta AB Pipeline Products by Equipment Type
Table 3: Elekta AB Pipeline Products by Indication
Table 4: Elekta AB, Key Facts
Table 5: Elekta AB, Major Products and Services
Table 6: Elekta AB Number of Pipeline Products by Development Stage
Table 7: Elekta AB Pipeline Products Summary by Development Stage
Table 8: Elekta AB Ongoing Clinical Trials by Trial Status
Table 9: Elekta AB Ongoing Clinical Trials Summary
Table 10: Digital Patient Monitoring Algorithm - Melanoma - Product Status
Table 11: Digital Patient Monitoring Algorithm - Melanoma - Product Description
Table 12: Elekta Esprit - Product Status
Table 13: Elekta Esprit - Product Description
Table 14: Elekta Unity - Product Status
Table 15: Elekta Unity - Product Description
Table 16: Elekta Unity - A Prospective, Phase II Study of MR-Linac Guided Adaptive Radiotherapy for Inoperable Mediastinal Tumor
Table 17: Elekta Unity - A Study to Evaluate the Efficacy of Elekta Unity in Patients with Localized Prostate Cancer
Table 18: Elekta Unity - Development of Daily Online Magnetic Resonance Imaging for Magnetic Resonance Image Guided Radiotherapy (MRIgRT)
Table 19: Elekta Unity - Feasibility of Imaging and Radiotherapy on a Novel 1.5 T Hybrid Magnetic Resonance Imaging - Linear Accelerator System (MR-Linac)
Table 20: Elekta Unity - Prospective Evaluation of Radiotherapy using Magnetic Resonance Image Guided Treatment (PERMIT)
Table 21: Elekta Unity - Prostate Radiotherapy Integrated with Simultaneous MRI (The PRISM Study)
Table 22: Elekta Unity - The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
Table 23: Harmony Pro - Product Status
Table 24: Harmony Pro - Product Description
Table 25: MOSAIQ Mobile - Product Status
Table 26: MOSAIQ Mobile - Product Description
Table 27: Next generation Gamma Knife - Product Status
Table 28: Next generation Gamma Knife - Product Description
Table 29: Next generation Gamma Knife - Regional Non-comparative Prospective Study of the Impact of Gamma Knife Radiosurgery on Tremor in Multiple Sclerosis
Table 30: Elekta AB, Key Employees
Table 31: Elekta AB, Key Employee Biographies
Table 32: Elekta AB, Other Locations
Table 33: Elekta AB, Subsidiaries
Table 34: Glossary
List of Figures
Figure 1: Elekta AB Pipeline Products by Equipment Type
Figure 2: Elekta AB Pipeline Products by Development Stage
Figure 3: Elekta AB Ongoing Clinical Trials by Trial Status

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us